WSJ editorial on issue of stem cells as drugs misses the boat
Today there is an editorial piece in the WSJ about the recent court ruling giving the FDA authority to regulate stem cells grown in culture as drugs. As a stem cell scientist, I read this opinion piece with interest. Unfortunately it is behind a paywall, but I have outlined and discussed the key issues below. […]
WSJ editorial on issue of stem cells as drugs misses the boat Read More »